Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage topoisomerase ii'

Search results for: 'research area dna damage topoisomerase ii'

Items 31-40 of 69

Page
per page
  1. EX 527 (SEN0014196)
    A4181 EX 527 (SEN0014196)
     1 Citation
    Target: Sirtuin
    Summary: SIRT1 inhibitor
      insoluble in H2O; ≥12.43 mg/mL
  2. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  3. MK-8776 (SCH-900776)
    A8477 MK-8776 (SCH-900776)
    Target: Chk
    Summary: Chk1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
  4. (-)-Blebbistatin
    B1387 (-)-Blebbistatin
     3 Citation
    Target: Myosin II ATPases
    Summary: Non muscle myosin II ATPase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.62 mg/mL
  5. PD123319
    B2206 PD123319
    Target: Angiotensin AT2 Receptors
    Summary: Angiotensin AT2 receptor antagonist
      ≥22.4 mg/mL
  6. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    Target: Topoisomerases
    Summary: Topoisomerase 1 inhibitor
      ≥23.1 mg/mL
  7. MC1568
    A4094 MC1568
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Class II HDAC inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
  8. Valsartan
    B2214 Valsartan
    Target: Angiotensin AT1 Receptors
    Summary: Angiotensin II AT1 receptor antagonist
  9. KN-93
    A3532 KN-93
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMKII inhibitor,selective and cometitive
      insoluble in H2O; ≥19.15 mg/mL
  10. Azilsartan
    B2210 Azilsartan
    Target: Angiotensin AT1 Receptors
    Summary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
      insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL

Items 31-40 of 69

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 66item
  2. Natural Products 1 item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 1 item
  3. Cathepsins 1 item
  4. Histone Deacetylases (HDACs) 2item
  5. Akt 1 item
  6. PI3K 4item
  7. mTOR 3item
  8. AP-1 1 item
  9. Myosin II ATPases 1 item
  10. Chk 2item
  11. Thymidylate Synthase 1 item
  12. Pim 2item
  13. PP1 1 item
  14. PP2A 1 item
  15. MET 1 item
  16. STAT 3item
  17. JAK 1 item
  18. DNA-PK 5item
  19. Angiotensin AT2 Receptors 3item
  20. CFTR 1 item
  21. Topoisomerases 8item
  22. DNA Methyltransferases 2item
  23. Calpains 1 item
  24. Ubiquitin-specific proteases 1 item
  25. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  26. USP 1 item
  27. 5-HT2 Receptors 1 item
  28. D1 and D5 Receptors 1 item
  29. D2 Receptors 1 item
  30. D3 Receptors 1 item
  31. 5-HT1 Receptors 1 item
  32. 5-HT7 Receptors 1 item
  33. Fatty-acid-binding proteins (FABPs) 1 item
  34. ATM/ATR 2item
  35. CK2 1 item
  36. HIPK2 1 item
  37. HIPK3 1 item
  38. HIV Integrases 1 item
  39. P2X Receptors 1 item
  40. Carbonic Anhydrases 1 item
  41. BLM 1 item
  42. Synthases/Synthetases 2item
  43. MAGL 1 item
  44. RNA Polymerases 1 item
  45. CMV 1 item
  46. Angiotensin AT1 Receptors 2item
  47. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  48. Cytidine deaminases 1 item
  49. PP4 1 item
  50. Dipeptidyl-peptidase II 1 item
  51. HCV polymerase 1 item
  52. ATM 1 item
  53. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 2item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. Breast Cancer 12item
  9. Cancer 46item
  10. Cervical Cancer 2item
  11. Cholangiocarcinoma 1 item
  12. Colon Cancer 8item
  13. Colorectal Cancer 5item
  14. Diabetes 1 item
  15. Glioblastoma 4item
  16. Glioma 1 item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 2item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 2item
  21. Leukemia 4item
  22. Lung Cancer 3item
  23. Lymphoma 5item
  24. Melanoma 5item
  25. Multiple Myeloma 2item
  26. Myeloma 2item
  27. Neuroblastoma 1 item
  28. Non-small Cell Lung Carcinoma 1 item
  29. Ovarian Cancer 8item
  30. Pancreatic Cancer 5item
  31. Prostate Cancer 6item
  32. Renal Cell Carcinoma 1 item
  33. Sarcoma 1 item
  34. Schizophrenia 1 item
  35. Squamous Cell Carcinoma 1 item
  36. Testicular Cancer 2item
  37. Type 2 Diabetes 2item